Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Apixaban Versus Warfarin for the Management of Post-operative Atrial Fibrillation: a Prospective, Controlled, Randomized Pilot Study

NCT02889562 is registered in ClinicalTrials.gov with Sanford Health as lead sponsor.

NCT NCT02889562
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02889562 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Apixaban Versus Warfarin for the Management of Post-operative Atrial Fibrillation: a Prospective, Controlled, Randomized Pilot Study
Lead sponsor
Sanford Health
Phase
Phase 2/3
Overall status
Completed
Start date
September 30, 2016
Completion date
May 11, 2019
Enrollment
56 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

coronary artery bypass grafting, deep venous thrombosis, postoperative atrial fibrilation, stroke, systemic embolism